Search Results for 'covid-19'
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
AMRI Contributes to Efforts to Increase COVID-19 Vax Supply
Joins network of approved manufacturers of lipid excipients for Pfizer-BioNTech COVID-19 vaccine.Tim Wright, Editor, Contract Pharma 02.25.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Pfizer, BioNTech To Supply 200M More Vax Doses to EU
New agreement brings total supply to the European Union to 500 million doses, with delivery expected by the end of 2021.Charles Sternberg, Assistant Editor 02.17.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
Kaneka Eurogentec Expands Capabilities
Receives GMP accreditation for new mRNA manufacturing facility, COVID-19 vaccine production ongoing.Tim Wright, Editor, Contract Pharma 02.17.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Pfizer, BioNTech to Supply the U.S. with 100mn Additional Doses of COVID-19 Vaccine
U.S. government exercises option to bring total supply to 300 million doses, enabling vaccinations for 150 million people.Tim Wright, Editor, Contract Pharma 02.12.21
-
Biologics, Proteins, Vaccines | Breaking News | Industry News
Evonik Strengthens Partnership with BioNTech on COVID-19 Vaccine
Establishment of additional lipid production in Germany for use with mRNA-based vaccines.Tim Wright, Editor, Contract Pharma 02.12.21
-
Biologics, Proteins, Vaccines | Clinical Trials
Inside a Vaccine Trial
Dr. Murphy of ICON, provider of clinical services to Pfizer/BioNTech’s COVID vaccine program, discusses what it takes to conduct a vaccine trial of this scale.Online Exclusives Kristin Brooks, Managing Editor 02.05.21
-
Biologics, Proteins, Vaccines | Breaking News | Industry News
CureVac, UK Partner on Vaccines Against SARS-CoV-2 Variants
Aims to mitigate the effects of the pandemic and help prepare against future SARS-CoV-2 outbreaks by working on multiple variant vaccines.Kristin Brooks 02.05.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Trials & Filings
J&J Submits EUA for Single-Shot Janssen COVID Vax Candidate
Plans to distribute vaccine to U.S. government immediately following authorization, and expects to supply 100 million doses in 1H21.Kristin Brooks 02.05.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Trials & Filings
Vaxart Oral COVID-19 Vax Tablet Shows Promise
Phase I study reached primary and secondary endpoints of safety and immunogenicity.Kristin Brooks 02.03.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Clinical Trials | Drug Development | Industry News
Immunome, Abzena Enter COVID-19 Antibody Cocktail Agreement
Abzena will work with Immunome to produce the antibody cocktail for clinical testing.Kristin Brooks 02.03.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News | Process Validation | Scale-up/Technology Transfer
Avid, Humanigen Enter Lenzilumab Mfg. Agreement
To expand production capacity for lenzilumab, Humanigen’s therapeutic candidate in development to treat cytokine storm associated with COVID-19.Kristin Brooks 02.03.21
-
Biologics, Proteins, Vaccines | cGMP Manufacture | Collaborations & Alliances
GSK, CureVac Enter New €150M COVID Vax Pact
GSK will support the manufacture of up to 100 million doses of CureVac’s first generation COVID-19 vaccine candidate CVnCoV in 2021.Kristin Brooks 02.03.21
-
Bio News | Breaking News | cGMP Manufacture | Clinical Trials | Collaborations & Alliances | Industry News
RedHill and Cosmo Expand Opaganib Manufacturing Deal
New agreement expands manufacturing capacity for orally-administered opaganib following positive top-line data from its Phase 2 COVID-19 study.Tim Wright, Editor, Contract Pharma 02.02.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Just, Evotec Expand mAbs Manufacturing Contract with DOD
Will manufacture anti-SARS-CoV-2 and other antibodies at J.POD facility in Washington state.Tim Wright, Editor, Contract Pharma 02.02.21
-
Breaking News | Clinical Trials | Drug Development | Industry News
DoD Awards Rigel $16.5M to Support Fostamatinib COVID Trials
Will evaluate the safety and efficacy of fostamatinib in hospitalized COVID-19 patients without respiratory failure.Kristin Brooks 02.01.21
-
Biologics, Proteins, Vaccines | Breaking News
UK Secures 40M Doses of Valneva COVID-19 Vax
Brings the total volume of the Valneva vaccine ordered by UK Government to 100 million doses.Charles Sternberg, Assistant Editor 02.01.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
CureVac, Rentschler Ramp up COVID Vax Production
Rentschler responsible for manufacturing, downstream processing and formulation of CureVac’s CVnCoV in Laupheim, Germany.Kristin Brooks 02.01.21
-
Aseptic Processing | Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Fill/Finish | Industry News
Novartis Inks Contract Manufacturing Deal for Pfizer-BioNTech COVID-19 Vaccine
Novartis to leverage manufacturing capacity and capabilities to address pandemic, supporting global supply of COVID-19 vaccine.Tim Wright, Editor, Contract Pharma 01.29.21
-
Biologics, Proteins, Vaccines
Vaccines 2021
Looking at the behavioral economics of vaccinations.Ben Locwin, Contributing Editor 01.27.21
-
COVID-19 Impact Report
Leaders across the pharmaceutical contract services industry reflect on the impact of COVID-19 in 2020, and what to expect in 2021.Tim Wright, Editor, Contract Pharma 01.27.21
-
Biologics, Proteins, Vaccines | Regulatory Affairs
The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021
A look at EUA standards and approvals, unavoidable pitfalls, Operation Warp Speed, FDA’s use of Real-World Evidence, and a slow return to “normalcy.”Chad Landmon, Michelle Divelbiss and Alex Alfano, Attorneys - Axinn, Veltrop & Harkrider LLP 01.27.21
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development
Lilly, Vir, GSK Partner to Evaluate COVID Combo Therapies
Lilly expands BLAZE-4 trial to evaluate bamlanivimab with VIR-7831, two neutralizing antibodies that bind to different epitopes of the SARS-CoV-2 spike protein.Kristin Brooks 01.27.21
-
Bio News | Breaking News | Collaborations & Alliances | Fill/Finish | Industry News | Parenterals
Ajinomoto Bio-Pharma, Humanigen Expand Manufacturing Agreement
Ajinomoto will support fill finish for investigational COVID-19 therapeutic, lenzilumab, nearing completion of phase 3 study.Tim Wright, Editor, Contract Pharma 01.27.21
-
Breaking News | Clinical Trials | Industry News
Care Access Research, AstraZeneca Partner on COVID-19 Antibody Trial
Care Access to provide decentralized, mobile research site operations for AstraZeneca’s AZD7442 Phase III trial in the U.S.Kristin Brooks 01.26.21
-
Breaking News | Facilities | Industry News | Injectables | Parenterals
Civica to Build an Essential Medicines Manufacturing Facility in Virginia
Will produce sterile injectable meds used in hospitals for COVID-19 patient care.Tim Wright, Editor, Contract Pharma 01.25.21
-
Bio News | Breaking News | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Industry News
Humanigen, Emergent Enter Covid-19 Partnership
Sign contract development and manufacturing agreement for Phase 3 COVID-19 therapeutic candidate lenzilumab.Tim Wright, Editor, Contract Pharma 01.25.21
-
Breaking News | Industry News
Pfizer, BioNTech Enter Vax Pact with COVAX
Initial agreement provides up to 40 million doses of the Pfizer-BioNTech COVID-19 Vaccine to COVAX in 2021, with first deliveries expected in 1Q21.Kristin Brooks 01.22.21
-
Breaking News | Clinical Trials | Industry News
Grifols Begins COVID-19 Plasma Treatment Trial
Treatment could be used for people who test positive for COVID-19, avoiding hospitalization due to the progression of the disease, complementing the vaccine.Contract Pharma Staff 01.18.21
-
-
Biologics, Proteins, Vaccines | Breaking News | Drug Delivery | Industry News
iosBio Inks Exclusive Vax Platform Pact for COVID-19
OraPro oral delivery vaccine platform technology enables oral administration of thermally-stable, viral vector vaccines.Contract Pharma Staff 01.12.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News | Parenterals
Baxter, Novavax Ink Sterile Manufacturing Agreement
CMO Baxter will help increase commercial production and promote access to Novavax' Covid-19 vax in UK and European markets.Contract Pharma Staff 01.11.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Fujifilm Diosynth Biotechnologies Begins COVID-19 Vax Production
Texas A&M System contract designates the CDMO’s Texas facility for emergency federal use.Contract Pharma Staff 01.11.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
AMRI Included in BARDA CDMO Network
Joins effort to support of COVID-19 pandemic response in the U.S.Contract Pharma Staff 01.11.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
CureVac and Bayer Join Forces
Collaborate to develop new Covid-19 vaccine candidate CVnCoV.Contract Pharma Staff 01.07.21
-
Biologics, Proteins, Vaccines | Breaking News | Industry News
Botanical Solution Inc. to Supply Pharma Grade QS-21 Vaccine Adjuvant
Secures $3.3 million in funding with second round planned for Spring 2021 to bolster growth.Contract Pharma Staff 01.06.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Industry News
Akston Biosciences and LakePharma Enter Covid-19 Partnership
Will manufacture second-generation COVID-19 vaccine, AKS-452.Contract Pharma Staff 01.05.21
-
Drug Development | Industry News | Regulatory Affairs
The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021
A look at EUA standards and approvals, unavoidable pitfalls, Operation Warp Speed, FDA’s use of Real-World Evidence, and a slow return to "normalcy".Chad Landmon, Michelle Divelbiss and Alex Alfano, Axinn, Veltrop & Harkrider LLP's Intellectual Property and Food and Drug Administration Practice Groups 01.05.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
INOVIO, Advaccine Enter Exclusive COVID-19 DNA Vax Pact
Partnership adds Asian manufacturing resource to INOVIO's global manufacturing consortium for INO-4800.Contract Pharma Staff 01.04.21
-
Biologics, Proteins, Vaccines | Breaking News | Fill/Finish | Formulation Development | Industry News
Moderna, Recipharm Enter COVID-19 Vax Mfg. Agreement
Recipharm to provide aseptic drug product manufacturing and fill-finish of Moderna’s COVID-19 vaccine outside of the U.S.Contract Pharma Staff 01.04.21
-
Breaking News | Industry News | Trials & Filings
Moderna Wins FDA Authorization for COVID-19 Vax
The primary efficacy analysis conducted on 196 cases indicated a vaccine efficacy rate of 94.1%.Contract Pharma Staff 12.21.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
BioNTech, Shanghai Fosun Pharma to Supply COVID-19 Vax to China
Sign an agreement to provide 100 million doses of their BNT162 mRNA-based vaccine candidate in 2021.Contract Pharma Staff 12.18.20
-
Cold Chain Management | Logistics
COVID-19 Vaccine Distribution: The Air Cargo Industry’s Greatest Challenge
How the air cargo logistics community is embracing technology to close critical gaps in the cold chain.Chris Jones, EVP, Marketing and Services, Descartes 12.15.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Pfizer, BioNTech Covid-19 Vax Authorized in the U.S.
First doses to be delivered across the nation today in healthcare facilities.Contract Pharma Staff 12.14.20
-
Breaking News | Industry News | Trials & Filings
Health Canada Authorizes Pfizer, BioNTech COVID-19 Vax
Pfizer Canada and BioNTech will supply the Government of Canada a minimum of 20 million doses and up to 76 million doses of the vaccine through 2021.Contract Pharma Staff 12.10.20
-
Breaking News | Cold Chain Management | Facilities | Industry News | Logistics | Supply Chain
Logistics4Pharma Facility Passes Inspection
German logistics firm completes validation of GDP cold chain storage and transportation at Frankfurt facility.Contract Pharma Staff 12.09.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Health Canada Green Lights COVID-19 Vax
Canadian regulator authorizes supply and emergency use of Pfizer and BioNTech’s COVID-19 mRNA vaccine.Contract Pharma Staff 12.09.20
-
Breaking News | cGMP Manufacture | Industry News
HALIX, AstraZeneca Ink Commercial COVID-19 Vax Mfg. Pact
HALIX to provide large-scale GMP manufacture of AZD1222 at its cGMP facility in the Netherlands.Contract Pharma Staff 12.08.20
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Lilly, UnitedHealth to Study Bamlanivimab in High-risk COVID-19
The study will identify and treat a large, diverse population of high-risk individuals for COVID-19 with bamlanivimab under real-world conditions.Contract Pharma Staff 12.04.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Keneka Eurogentec Joins Inovio’s Global Mfg. Consortium
Agrees to manufacture Innovio’s Covid-19 vaccine candidate INO-4800.Contract Pharma Staff 12.03.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Batavia Biosciences and KU Leuven Join Forces
Will accelerate the development of a highly promising Covid-19 vaccine candidate.Contract Pharma Staff 12.03.20
